Cargando…
Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
We evaluated the association between aspirin, statins, and metformin use and prostate cancer (PC) incidence and mortality using a large population-based dataset. 388,760 men who participated in national health screening program in Korea during 2002–2003 were observed from 2004 to 2013. Hazard ratios...
Autores principales: | Koo, Hye Yeon, Jeong, Su-Min, Cho, Mi Hee, Chun, Sohyun, Shin, Dong Wook, Park, Jinsung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352896/ https://www.ncbi.nlm.nih.gov/pubmed/34373584 http://dx.doi.org/10.1038/s41598-021-95764-3 |
Ejemplares similares
-
Associations of aspirin, statins and metformin with lung cancer risk and related mortality
por: Frille, Armin, et al.
Publicado: (2021) -
Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes
por: Orchard, Suzanne G, et al.
Publicado: (2023) -
Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
por: Moyad, Mark A, et al.
Publicado: (2015) -
Associations between Metformin and Aspirin Use on Cancer Incidence and Mortality in Older Adults.
por: Orchard, Suzanne, et al.
Publicado: (2021) -
Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy
por: Gash, K J, et al.
Publicado: (2017)